Cargando…
Bioavailability of nanomaterials: bridging the gap between nanostructures and their bioactivity
Instead of the nanostructure and biological activity, this perspective highlights the metabolic processes from biotransformation to bioavailability, to bridge the gap between the cradle (structure design) and endpoint (efficacy and/or safety) of nanomedicines.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522388/ https://www.ncbi.nlm.nih.gov/pubmed/36196113 http://dx.doi.org/10.1093/nsr/nwac119 |